Neuraxpharm Expands Into Brazil And Mexico

CNS Specialist Acquires Libber Pharma To Gain Infrastructure In Brazil

In a two-pronged push into Latin America, European CNS specialist Neuraxpharm has set up operations in Mexico and Brazil, with the latter bolstered by the acquisition of local player Libber Pharma.

Brazil and Mexico flags
Neuraxpharm has made moves into Latin America • Source: Shutterstock

Neuraxpharm has announced its latest push into new markets, taking the “first steps in its expansion outside of Europe” by establishing affiliates in Brazil and Mexico, “the two largest pharmaceutical markets in Latin America.”

In Brazil, the specialist in central nervous system treatments said a portfolio of products recently acquired from Sanofi – through a deal that was announced a year ago and closed early in 2023 (see sidebar) – would be combined with infrastructure gained through the

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

More from Business